TIMP1 was found to be a sensitive biomarker in patients with metastatic colon cancer, and higher TIMP1 levels were linked to lymph node metastases, vascular invasion and distant metastasis in CRC patients (31, 32). The gene discussed is TIMP1; the disease is metastatic malignant neoplasm in the lymph nodes.